Two novel lncRNAs AF111167.2 and AL162377.1 targeting miR-21-5p mediated down expression of SYDE2 correlates with poor prognosis and tumor immune infiltration of ccRCC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Two novel lncRNAs AF111167.2 and AL162377.1 targeting miR-21-5p mediated down expression of SYDE2 correlates with poor prognosis and tumor immune infiltration of ccRCC

Published:2022-10 Issue:10 Volume:8 Page:e11079
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Cui Yuanshan,Wu Jitao,Zhou Zhongbao,Ma Jian,Dong Liying

Funder

Taishan Scholar Project of Shandong Province

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference24 articles.

1. Epidemiology of renal cell carcinoma;Capitanio;Eur. Urol.,2019

2. Renal cell carcinoma: a review of biology and pathophysiology;Nabi;F1000Res,2018

3. Sequencing of agents for metastatic renal cell carcinoma: can we customize therapy?;Sonpavde;Eur. Urol.,2012

4. A key oncofoetal transcription factor in health and disease;Bella;Semin. Cancer Biol.,2014

5. Systemic therapy in metastatic renal cell carcinoma;Bedke;World J. Urol.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-coding transcriptome profiles in clear-cell renal cell carcinoma;Nature Reviews Urology;2024-09-06

2. Establishment of a prognostic signature of disulfidptosis-related lncRNAs for predicting survival and immune landscape in clear cell renal cell carcinoma;Oncologie;2024-06-03

3. Integrated transcriptomic and immunological profiling reveals new diagnostic and prognostic models for cutaneous melanoma;Frontiers in Pharmacology;2024-05-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP